Kunming Longjin Pharmaceutical Co Ltd (002750) - Total Assets

Latest as of March 2025: CN¥555.15 Million CNY ≈ $81.24 Million USD

Based on the latest financial reports, Kunming Longjin Pharmaceutical Co Ltd (002750) holds total assets worth CN¥555.15 Million CNY (≈ $81.24 Million USD) as of March 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore how well can Kunming Longjin Pharmaceutical Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.

Kunming Longjin Pharmaceutical Co Ltd - Total Assets Trend (2011–2024)

This chart illustrates how Kunming Longjin Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. See 002750 net assets for net asset value and shareholders' equity analysis.

Kunming Longjin Pharmaceutical Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Kunming Longjin Pharmaceutical Co Ltd's total assets of CN¥555.15 Million consist of 58.9% current assets and 41.1% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	45.6%
Accounts Receivable	CN¥8.75 Million	1.5%
Inventory	CN¥21.86 Million	3.8%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥58.20 Million	10.1%
Goodwill	CN¥0.00	0.0%

Asset Composition Trend (2011–2024)

This chart illustrates how Kunming Longjin Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Kunming Longjin Pharmaceutical Co Ltd.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Kunming Longjin Pharmaceutical Co Ltd's current assets represent 58.9% of total assets in 2024, an increase from 37.5% in 2011.
Cash Position: Cash and equivalents constituted 45.6% of total assets in 2024, up from 22.1% in 2011.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 7.0% in 2011.
Asset Diversification: The largest asset category is intangible assets at 10.1% of total assets.

Kunming Longjin Pharmaceutical Co Ltd Competitors by Total Assets

Key competitors of Kunming Longjin Pharmaceutical Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	China	CN¥2.30 Billion
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	China	CN¥8.59 Billion
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	China	CN¥925.41 Million
Jw Pharmac KO:001060	Korea	₩605.27 Billion
Kamada TA:KMDA	Israel	ILA377.21 Million
Samjin Pharm KO:005500	Korea	₩449.14 Billion

Kunming Longjin Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	7.94	5.97	5.30
Quick Ratio	7.29	5.57	4.92
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥271.92 Million	CN¥327.68 Million	CN¥384.35 Million

Kunming Longjin Pharmaceutical Co Ltd - Advanced Valuation Insights

This section examines the relationship between Kunming Longjin Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	0.51
Latest Market Cap to Assets Ratio	0.06
Asset Growth Rate (YoY)	-9.1%
Total Assets	CN¥574.40 Million
Market Capitalization	$34.58 Million USD

Valuation Analysis

Below Book Valuation: The market values Kunming Longjin Pharmaceutical Co Ltd's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Kunming Longjin Pharmaceutical Co Ltd's assets decreased by 9.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Kunming Longjin Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual total assets of Kunming Longjin Pharmaceutical Co Ltd from 2011 to 2024.

Year	Total Assets	Change
2024-12-31	CN¥574.40 Million ≈ $84.05 Million	-9.06%
2023-12-31	CN¥631.63 Million ≈ $92.43 Million	-15.47%
2022-12-31	CN¥747.21 Million ≈ $109.34 Million	-9.68%
2021-12-31	CN¥827.28 Million ≈ $121.06 Million	-1.72%
2020-12-31	CN¥841.76 Million ≈ $123.18 Million	+4.32%
2019-12-31	CN¥806.89 Million ≈ $118.07 Million	+2.46%
2018-12-31	CN¥787.55 Million ≈ $115.24 Million	+0.30%
2017-12-31	CN¥785.23 Million ≈ $114.90 Million	+3.36%
2016-12-31	CN¥759.68 Million ≈ $111.17 Million	+8.70%
2015-12-31	CN¥698.86 Million ≈ $102.27 Million	+60.44%
2014-12-31	CN¥435.59 Million ≈ $63.74 Million	-1.58%
2013-12-31	CN¥442.56 Million ≈ $64.76 Million	+20.24%
2012-12-31	CN¥368.05 Million ≈ $53.86 Million	+28.08%
2011-12-31	CN¥287.36 Million ≈ $42.05 Million	--

About Kunming Longjin Pharmaceutical Co Ltd

SHE:002750 China Drug Manufacturers - Specialty & Generic

Market Cap

$34.58 Million

CN¥236.29 Million CNY

Market Cap Rank

#23221 Global

#4714 in China

Share Price

CN¥0.59

Change (1 day)

+0.00%

52-Week Range

CN¥0.59 - CN¥0.59

All Time High

CN¥25.99